Evidence map›Paper›PMID 39505736›Full record

ArticleEuropean radiology2025

Repeatability of quantitative MR fingerprinting for T

Mihaela Rata, Matthew R Orton, Nina Tunariu, Andra Curcean, Julie Hughes, Erica Scurr, Matthew Blackledge, James d'Arcy, Yun Jiang, Vikas Gulani and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Serial TEuropean radiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mihaela RataDepartment of Radiology, MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK. Mihaela.Rata@rmh.nhs.uk.ORCID http://orcid.org/0000-0003-4999-8038
Matthew R OrtonDepartment of Radiology, MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Nina TunariuDepartment of Radiology, MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Andra CurceanDepartment of Radiology, MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Julie HughesDepartment of Radiology, MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Erica ScurrDepartment of Radiology, MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Matthew BlackledgeDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
James d'ArcyDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
Yun JiangDepartment of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Vikas GulaniDepartment of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Dow-Mu KohDepartment of Radiology, MRI Unit, The Royal Marsden NHS Foundation Trust, London, UK.

Funding

3D High Resolution Magnetic Resonance Fingerprinting for Prostate CancerR37CA263583 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Yun Jiang · 2021 to 2026
$3.8M
Quantitative MRI to automatically delineate intraprostatic tumor for radiation therapyR01CA284172 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI GUO, JIA, JIANG, YUN · 2024 to 2025
$1.4M
NCI NIH HHS R01 CA284172NCI NIH HHS R37 CA263583
6 · The paper itself

Abstract

objectivesMR fingerprinting (MRF) has the potential to quantify treatment response. This study evaluated the repeatability of MRF-derived T MATERIALS AND

methodsThis prospective single-centre study included same-day repeated MRF acquisitions from 20 patients (August 2019-October 2020). Phantom and human data were acquired on a 1.5-T MR scanner using a research MRF sequence outputting T

resultsTwenty patients with metastatic prostate cancer (mean age, 70 years ± 8 (standard deviation)) were evaluated and bone metastasis (n = 44), normal-appearing bone (n = 14), and muscle (n = 20) ROIs were delineated. Relative repeatability of T

conclusionMRF allows repeatable T KEY POINTS: Question MR fingerprinting has the potential to characterise bone metastasis and its response to treatment. Findings Repeatability of MRF-based T

Indexed as

Bone NeoplasmsMagnetic Resonance ImagingProstatic NeoplasmsAgedHumansMaleMiddle AgedPhantoms, ImagingProspective StudiesReproducibility of ResultsBoneMetastasisMR fingerprintingProstate cancer

Identifiers

PMID39505736
PMCPMC12021959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.